Toro-Calzada RJ, Estrada-Soria ML

Idioma: Español
Referencias bibliográficas: 34
Paginas: 185-191
Archivo PDF: 320.97 Kb.

RESUMEN

Revisión de la efectividad de la anticoncepción de emergencia con métodos hormonales y dispositivos intrauterinos. De los métodos hormonales, en orden de efectividad está el acetato de ulipristal, fármaco que ha demostrado su eficacia en la pre y periovulación. Los moduladores de receptores de progesterona también son una buena opción, aunque en nuestro país no están disponibles las presentaciones adecuadas para su prescripción en la anticoncepción de emergencia. La monodosis y la dosis en dos tomas de levonorgestrel es igual de efectiva y es la más prescrita en nuestro país. Sin embargo, el esquema de Yuspe está en desuso. El dispositivo intrauterino de cobre es el de mayor efectividad, aunque requiere de personal adiestrado y de condiciones estériles para su inserción.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Organización Mundial de la Salud. Anticoncepción de emergencia. Nota descriptiva 244. Julio 2012.

2. Barbato WR, Charalmbopoulos JT. Tratado de anticoncepción. Editorial Corpus 2005.

3. Gemzell-Danielsson K, Rabe T, Cheng L. Emergency contraception. Gynecol Endocrinol 2013;1:1-14.

4. Yuspe AA, Thurlow HJ, Ramsy I, Leyshon JI. Postcoital contraception: a pilot study. J Reprod Med 1974;13:53-58.

5. Ary AH. Emergency contraception. Contraception 1994;50:101-108.

6. Croxatto HBM, Brache V, Pavez M, Cochon L, et al. Pituitaryovarian function following the standard levonorgstrel emergency conctraceptive dose or a single 0.75 mg dose given on the days preceding ovulation. Contraception 2004;70:442-450.

7. Ortiz ME, Ortiz RE, Fuentes M, Parraguez VH, Croxatto HB. Poscoital administration of levonorgestrel does not interfere with post-fertilization events in the new-world monkeky Cebus apella. Human Reprod 2004;19:1352-1356.

8. Gemzell-Danielsson K, Berger C, Lalitkumar PGL. Emegency contraception-mechanisms of action. Contraception 2013;87:300-308.

9. Brache V, Cochon L, Deniaus M, Croxatto HB. Ulipristal acetate prevents ovulation more effectively than levonorgestrel: analysis of pooled data from three randomized trial of emergency contraception regimens. Contraception 2013;88:611-618.

10. Creinin MD, Schlaff W, Archer DF, Wan L, et al. Progesterone receptor modulator or emergency contracepltion: A randomized controlled trial. Obstetrics Gynecol 2006;108:1089-1097.

11. Wu S, Dong J, Cong J, Wang C, et al. Gestrinone compared with mifepristone for emergency contraception. Obstet Gynecol 2010;115:740-744.

12. McCann NC, Lynch TJ, Kim SO, Duffy DM. The COC-2 inhibitor meloxicam prevents pregnancy when administred as an emegency contraceptive to nonhuyman primates. Contraception 2013;88:744-748.

13. Jesam C, Salvatierra AM, Schwartz JL, Croxatto HB. Suppression of folicular rupture with meloxicam, a cyclooxygenase- 2 inhibitor: potential for emergency contraception. Human Reprod 2010;25:368-373.

14. Massai MR, Forcelledo ML, Brache V, Tejada AS, et nal. Does meloxicam increase the incidence of anovulation induced by single administration of levonorgestrel in emergency contraception? A pilot study. Human Reprod 2007;22:434-439.

15. Glasier Anna. Emergency contraception: clinical outcomes. Contraception 2012;87:309-313.

16. Dada OA, Godfrey EM, Piaggio G, Von Hertzen H. A randomized, double-bind, noninferiority study to compare two regimens of levonorgestrel for emergency contraception in Nigeria. Contraception 2010;82:373-378.

17. Noé G, Coxatto HB, Salvatierra AM, Reyes V, et al. Contraceptive efficacy of emergency contraception with levonorgestrel given before or after ovulation. Contraception 2011;84:486-492.

18. Cheng L, Che Y, Gûlmezoglu AM. Interventions for emergency contraception. Cochrane Database Syst Rev 2012;15:1324.

19. Richardson AR, Maltz FN. Ulipristal acetate: review of the efficacy and safety of a newly approved agent for emergency contraception. Clin Ther 2012;34:24-36.

20. Fine P, Mathe H, Ginde S, Cullins V, et al. Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception. Obstet Gynecol 2010;115:257-263.

21. Moreau C, Trussell J. Results from pooled phase III studies of ulipristal acetate for emergency contraception. Contraception 2012;86:673-680.

22. Turok DK, Godfrey EM, Wojdyla D, Dermish A, et al. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle. Human Reprod 2013;28:2672-2676.

23. Wu S, Godfrey Em, Wojdyla D, Dong J, et al. Cooper T380 A intrauterine device for emergency contraception: a prospective, multicenter, cohort clinical trial. BJCOG 2010;117:1205-1210.

24. Cleland K, Zhu H, Goldstuck N, Cheng L, Trussell J. The efficacy of intrauterine devices for emergency contraception: a systematic review of 35 years of experience. Human Reprod 2012;27:1994-2000.

25. Turok DK, Godfrey EM, Wojdyla D, Dermish A, et al. Copper T380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle. Human Reprod 2013;28:2672-2676.

26. Zhou L, Xiao B. Emergency contraception with Multiload Cu-375 SL IUD: a multicenter clinical trial. Contraception 2001;64:107-112.

27. Von Hertzen, et al. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: a WHO multicenter randomised trial. Lancet 2002;360:1803-1810.

28. Glasier AF, Cameron ST, Fine PM, Logan SJ, et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non–inferiority trial and meta-analysis. Lancet 2010;375:555-562.

29. Fine PM. Ulipristal acetate: a new emergency contraceptive that is safe and more effective than levonorgestrel. Womens Health 2011;7:9-17.

30. Turok DK, Jacobson JC, Dermish AI, Simonsen SE, et al. Emergency contraception with a copper IUD or oral levonorgestrel: an observational study of 1-year pregnancy rates. Contraception 2013:88:732-734.

31. Turok DK, Gurtcheff SE, Handley E, Simonsen SE, et al. A pilot study of the Copper T380A IUD and oral levonorgestrel for emergency contraception. Contraception 2010;82:520-525.

32. Glasier A, Cameron ST, Blithe D, Scherrer B, et al. Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel. Contraception 2011;84:363-367.

33. Rodriguez MI, Curtis KM, Gaffield ML, Jackson E, Kapp N. Advance supply of emergency contraception: a systematic review. Contraception 2013;87:590-601.

34. ACOG. Practice Bulletin 112. Emergency contraception 2010.